Nuclear Medicine
CLINICAL DECISION SUPPORT
| Clinical Evaluation |
|---|
| Glucose metabolism |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| A (strongly recommended) |
| Level of Evidence |
| well-established clinical and NM recommendations recommendations |
| Effective Dose |
| 19.0 µSv/MBq |
| Bibliographic Reference |
|
National Comprehensive Cancer Network. (2021). NCCN Guidelines https://www.nccn.org/guidelines/nccn-guidelines - NSCLC, Version 6.2021. Pos... read more National Comprehensive Cancer Network. (2021). NCCN Guidelines https://www.nccn.org/guidelines/nccn-guidelines - NSCLC, Version 6.2021. Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, Escriu C, Peters S; ESMO Guidelines Committee. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017; https://doi.org/10.1093/annonc/mdx222 ESTRO ACROP Consensus Guideline for SBRT in NSCLC: Guckenberger M, Andratschke N, Dieckmann K, Hoogeman MS, Hoyer M, Hurkmans C, Tanadini-Lang S, Lartigau E, Méndez Romero A, Senan S, Verellen D. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiothel Oncol. 2017;. https://doi.org/10.1016/j.radonc.2017.05.012 read less |
| Guide to Nuclear Medicine |
| Read the corresponding chapter |